Insights+

Disease of the Month – Sjögren’s Syndrome

Disease of the Month – Sjögren’s Syndrome

Shots:  A rare autoimmune condition, Sjögren’s Syndrome is ch...

Insights+: The US FDA New Drug Approvals in April 2024

Insights+: The US FDA New Drug Approvals in April 2024

Shots:   PharmaShots has compiled a list of US FDA-approved drugs in the...

Insights+ Key Biosimilars Events of April 2024

Insights+ Key Biosimilars Events of April 2024

Shots:    Biosimilars are developed to be highly similar vers...

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2004-2023)

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2004-2023)

Shots:   Witness the journey of the biopharma companies over 20 ye...

New Drug Designations - March 2024

New Drug Designations - March 2024

Shots:  PharmaShots' designation report provides a concise overview...

Know Your Investor (April Edition): OrbiMed Advisors

Know Your Investor (April Edition): OrbiMed Advisors

Shots: An American investment firm, OrbiMed Advisor is a prominent name when it co...

Image